Tim H. Brümmendorf
Düsseldorf University Hospital(DE)Universitätsklinikum Aachen(DE)Centrum für Integrierte Onkologie(DE)Heinrich Heine University Düsseldorf(DE)RWTH Aachen University(DE)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes
Most-Cited Works
- → Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants(2017)328 cited
- → Telomere length in leukocyte subpopulations of patients with aplastic anemia(2001)229 cited
- → Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase(2008)198 cited
- → Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party(2012)180 cited
- → Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry(2016)180 cited
- → Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation(2011)